Fortis Healthcare

| May 27, 2016

NEW DELHI: Indian healthcare company Fortis Healthcare is set to turn its diagnostic chain SRL Diagnostics into a separate unit prior to getting it listed, thus providing an exit route to private equity investors, said two people familiar with the development. SRL Diagnostics had appointed Moelis & Co. advisor last year as part of efforts to give PE firms such as International Finance Corporation, NYLIM Jacob Ballas and Avigo Capital Partners an exit......

Business Standard | May 26, 2019

Fortis Healthcare showed signs of revival in the fourth quarter of FY19, with improved earnings before interest, tax, depreciation and amortisation (Ebitda). The Gurugram-headquartered health care major reported net profit (profit after tax and minority interests) of Rs 135.6 crore after accounting for exceptional items for the fourth quarter of the FY19. This was against a loss of Rs 932 crore in the same period last year. Exceptional items for the quarter primarily include allowance for doubtf...

ndtv | May 06, 2016

Shares of companies promoted by Malvinder Mohan Singh and Shivinder Mohan Singh came under selling pressure on Friday, following a Rs 2,600 crore penalty imposed on the billionaire brothers in a 2008 deal involving the sale of Ranbaxy to Daiichi Sankyo. (Read) Fortis Healthcare shares fell nearly 5 per cent on Friday, while Religare Enterprises shares traded 1 per cent lower. Both Fortis and Religare shares were headed for a fourth straight day of losses....

EHRIntelligence | January 16, 2020

Eighty-four percent of EHR users are dissatisfied with the technical service and basic software account support from current EHR and HIT vendors, according to a 2020 Black Book Research survey. Since the HITECH Act was signed into law in 2009, EHRs have not only been more prevalent, but they have continued to change and evolve. However, technical service from EHR vendors hasn’t kept up with the constant change, according to high-level hospital tech managers. Healthcare software support is ...